Guggenheim Capital’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $833K | Buy |
6,062
+1,909
| +46% | +$262K | 0.01% | 947 |
|
|
2025
Q1 | $749K | Sell |
4,153
-709
| -15% | -$128K | 0.01% | 1010 |
|
|
2024
Q4 | $762K | Buy |
4,862
+927
| +24% | +$145K | 0.01% | 1033 |
|
|
2024
Q3 | $716K | Sell |
3,935
-774
| -16% | -$141K | 0.01% | 1251 |
|
|
2024
Q2 | $865K | Buy |
4,709
+373
| +9% | +$68.5K | 0.01% | 1190 |
|
|
2024
Q1 | $772K | Sell |
4,336
-1,103
| -20% | -$196K | 0.01% | 1298 |
|
|
2023
Q4 | $675K | Buy |
+5,439
| New | +$675K | 0.01% | 1328 |
|